BioSpace News Archive

Twist Bioscience Corporation today announced that the company has joined the U.S. AI Safety Institute Consortium (AISIC), a group established by the Department of Commerce’s National Institute of Standards and Technology (NIST) to support the development and deployment of trustworthy and safe AI.

Bristol Myers Squibb announced the first presentation of results from the Phase 3 CheckMate -9DW trial evaluating the dual immunotherapy combination of Opdivo® plus Yervoy® compared to investigator’s choice of lenvatinib or sorafenib as a first-line treatment for patients with unresectable hepatocellular carcinoma.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program.

Seismic Therapeutic, Inc today announced that the company will participate in three upcoming scientific conferences.

Nalu Medical Inc. revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation System utilizing their proprietary micro-implantable pulse generator to treat chronic pain patients.

Theralase Technologies Inc. is pleased to announce that it’s lead compound, Ruvidar TM, has been proven effective in the inactivation of various viruses.

Axena Health, Inc., a medical device company focused on female pelvic health, has closed on an additional $9.4 million in its Series A fundraising.

Mission Bio today announced the launch of the Tapestri® Single-cell Multiple Myeloma Multiomics Solution.

Guardant Health, Inc., a leading precision oncology company, announced the launch of a new version of its Guardant360 TissueNext test that expands the number of genes it identifies in a tumor tissue sample to 498.

LabWare, a global leader in Laboratory Information Management Systems (LIMS) within the Pharma and BioPharma industry, last month played a key role in spearheading and guiding an exploratory delegation led by the Governor of Delaware to investigate and exchange opportunities within Ireland’s BioPharma sector.